Skip to main content

previous disabled Page of 2
and
Your search also matched 30 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

A real-time semi-dense depth-guided depth completion network

Include preview-only content
  1. Article

    Open Access

    Dual-loss of PBRM1 and RAD51 identifies hyper-sensitive subset patients to immunotherapy in clear cell renal cell carcinoma

    Homologous recombination deficiency (HRD), though largely uncharacterized in clear cell renal cell carcinoma (ccRCC), was found associated with RAD51 loss of expression. PBRM1 is the second most common mutated...

    Ziyang Xu, Wenbin Jiang, Li Liu, Youqi Qiu, Jiahao Wang in Cancer Immunology, Immunotherapy (2024)

  2. Article

    Open Access

    Integrative score based on CDK6, PD-L1 and TMB predicts response to platinum-based chemotherapy and PD-1/PD-L1 blockade in muscle-invasive bladder cancer

    Cyclin-dependent kinase 6 (CDK6) was proved to be an important regulator in the progression of cell cycle and has been a promising therapeutic target in cancer treatment. However, the clinical significance of ...

    **aohe Su, Kaifeng **, Qiji Guo, Ziyue Xu, Zhaopei Liu in British Journal of Cancer (2024)

  3. Article

    Open Access

    C-type lectin receptor Dectin-1 blockade on tumour-associated macrophages improves anti-PD-1 efficacy in gastric cancer

    This study aimed to investigate the expression and clinical significance of Dendritic cell-associated C-type lectin-1 (Dectin-1) in gastric cancer (GC), and to explore the mechanism of Dectin-1 regulating tumo...

    **n Liu, Kunpeng Lv, Jieti Wang, Chao Lin, Hao Liu, Heng Zhang in British Journal of Cancer (2023)

  4. Article

    Open Access

    Intratumoral PD-1+CD8+ T cells associate poor clinical outcomes and adjuvant chemotherapeutic benefit in gastric cancer

    Although PD-1 has been reported to be a marker of T-cell exhaustion in several malignancies, the biological role of PD-1+CD8+ T cells in gastric cancer (GC) remains unclear. Herein, we aimed to investigate the ro...

    Kuan Yu, Yun Gu, Puran Zhang, Hanji Fang, Yifan Cao in British Journal of Cancer (2022)

  5. Article

    Open Access

    Author Correction: EZH2-mediated loss of miR-622 determines CXCR4 activation in hepatocellular carcinoma

    Haiou Liu, Yidong Liu, Weisi Liu, Weijuan Zhang, Jiejie Xu in Nature Communications (2021)

  6. Article

    Open Access

    Blocking siglec-10hi tumor-associated macrophages improves anti-tumor immunity and enhances immunotherapy for hepatocellular carcinoma

    Tumor-associated macrophages (TAMs) promote key processes in the modulation of tumor microenvironment (TME). However, the clinical significance of heterogeneous subpopulations of TAMs in hepatocellular carcino...

    Nan **ao, **aodong Zhu, Kangshuai Li, Yifan Chen in Experimental Hematology & Oncology (2021)

  7. Article

    Open Access

    Intratumoral CXCR5+CD8+T associates with favorable clinical outcomes and immunogenic contexture in gastric cancer

    Studies that examined an association between CD8+T and prognosis in gastric cancer are inconsistent, and a distinct population of CXCR5+CD8+T associated with better overall survival has been reported among variou...

    Jieti Wang, Ruochen Li, Yifan Cao, Yun Gu, Hanji Fang, Yuchao Fei in Nature Communications (2021)

  8. Article

    Open Access

    Identification and validation of an immunogenic subtype of gastric cancer with abundant intratumoural CD103+CD8+ T cells conferring favourable prognosis

    Intratumoural CD103+CD8+ T cells have been linked to prolonged survival in several malignancies. However, the clinical significance of CD103+CD8+ T cells in gastric cancer remains unexplored.

    Ruochen Li, Hao Liu, Yifan Cao, Jieti Wang, Yifan Chen in British Journal of Cancer (2020)

  9. Article

    Open Access

    B4GALT1 expression predicts prognosis and adjuvant chemotherapy benefits in muscle-invasive bladder cancer patients

    The expression alterations of B4GALT1 have been noted in some types of cancer and they are related to cancer cell proliferation, invasiveness, metastasis, and drug resistance. We aimed to establish the express...

    Huyang **e, Yu Zhu, Junyu Zhang, Zheng Liu, Hangcheng Fu, Yifan Cao in BMC Cancer (2018)

  10. Article

    Open Access

    Tumor-infiltrating mast cells predict prognosis and gemcitabine-based adjuvant chemotherapeutic benefit in biliary tract cancer patients

    Recent studies have reported TIMs play an important role in tumors progression or regression, but the effect of TIMs in biliary tract cancer remains unclear. The aim of this study is to investigate the prognos...

    **aobo Bo, Jie Wang, Tao Suo, **aoling Ni, Han Liu, Sheng Shen, Min Li in BMC Cancer (2018)

  11. Article

    Open Access

    Low CCL17 expression associates with unfavorable postoperative prognosis of patients with clear cell renal cell carcinoma

    Chemokine (C–C motif) ligand 17 (CCL17) is a chemokine mainly produced by myeloid dendritic cells. It is a ligand for CC chemokine receptor 4 (CCR4) and CC chemokine receptor 8 (CCR8). The aim of this study wa...

    Ying **ong, Li Liu, Yu **a, Jiajun Wang, Wei **, Qi Bai, Yang Qu, Jiejie Xu in BMC Cancer (2017)

  12. Article

    Open Access

    Prognostic value of CC-chemokine receptor seven expression in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitor

    CC-chemokine receptor seven (CCR7), a G-protein coupled receptor normally facilitating immune cells lymphatic homing, has recently been identified on several cancer cells in promoting invasion and lymphatic sp...

    Yu **a, Li Liu, Ying **ong, Qi Bai, Jiajun Wang, Wei **, Yang Qu, Jiejie Xu in BMC Cancer (2017)

  13. Article

    Open Access

    Glycoprotein 130 is associated with adverse postoperative clinical outcomes of patients with late-stage non-metastatic gastric cancer

    The interaction of glycoprotein 130 (gp130) with the cytokines of Interleukin-6 (IL-6) family has proved to play a crucial part in several cancers. Our current study is designed to discover the clinical progno...

    Yifan Cao, Heng Zhang, Hao Liu, Chao Lin, Ruochen Li, Songyang Wu in Scientific Reports (2016)

  14. Article

    Open Access

    Dectin-1 predicts adverse postoperative prognosis of patients with clear cell renal cell carcinoma

    Dectin-1, a classical pattern-recognition receptor, was now identified as an important regulator in immune homeostasis and cancer immunity through its extensive ligands binding functions and subsequent cytokin...

    Yu **a, Li Liu, Qi Bai, Jiajun Wang, Wei **, Yang Qu, Ying **ong in Scientific Reports (2016)

  15. Article

    Open Access

    High Level of Anaphylatoxin C5a Predicts Poor Clinical Outcome in Patients with Clear Cell Renal Cell Carcinoma

    Anaphylatoxin C5a, a potent pro-inflammatory peptide produced in the process of complement activation, was proved to have a vital role in tumor initiation and progession by previous investigations. However whe...

    Wei **, Li Liu, Jiajun Wang, Yu **a, Qi Bai, Qilai Long, Yiwei Wang in Scientific Reports (2016)

  16. Article

    Open Access

    Increased expression of IDO associates with poor postoperative clinical outcome of patients with gastric adenocarcinoma

    Clinical significance of 2,3-dioxygenase (IDO) has been studied in types of tumors, but the role that IDO played in gastric adenocarcinoma (GAC) is still unclear. Here, we aim to investigate the prognostic val...

    Hao Liu, Zhenbin Shen, Zhenglin Wang, Xuefei Wang, Heng Zhang in Scientific Reports (2016)

  17. Article

    Open Access

    Prognostic value of interleukin-6 and interleukin-6 receptor in organ-confined clear-cell renal cell carcinoma: a 5-year conditional cancer-specific survival analysis

    Interleukin-6 (IL-6) is the major cytokine that induces transcriptional acute and chronic inflammation responses, and was recently incorporated as a recurrence prognostication signature for localised clear-cel...

    Qiang Fu, Yuan Chang, Huimin An, Hangcheng Fu, Yu Zhu, Le Xu in British Journal of Cancer (2015)

  18. Article

    Open Access

    High expression of Solute Carrier Family 1, member 5 (SLC1A5) is associated with poor prognosis in clear-cell renal cell carcinoma

    Solute Carrier Family 1, member 5 (SLC1A5), also named as ASCT2, a major glutamine transporter, is highly expressed in various malignancies and plays a critical role in the transformation, growth and survival ...

    Yidong Liu, Liu Yang, Huimin An, Yuan Chang, Weijuan Zhang, Yu Zhu in Scientific Reports (2015)

  19. Article

    Open Access

    Prognostic significance of ST3GAL-1 expression in patients with clear cell renal cell carcinoma

    Aberrant sialylated carbohydrate synthesis is frequently noted in various cancers. Sialyltransferase ST3GAL-1, which adds a sialic acid in an α-2,3 linkage to Gal β1,3 GalNAc, preforms an important role in mod...

    Qi Bai, Li Liu, Yu **a, Qilai Long, Jiajun Wang, Jiejie Xu, Jianming Guo in BMC Cancer (2015)

  20. Article

    Open Access

    The prognostic value of CXC-chemokine receptor 2 (CXCR2) in gastric cancer patients

    CXC chemokine receptor 2 (CXCR2) has been reported to play an important role in the proliferation and invasion of gastric cancer cells. The present study aims to investigate the impact of CXCR2 expression on t...

    Zhenglin Wang, Hao Liu, Zhenbin Shen, Xuefei Wang, Heng Zhang, **g Qin in BMC Cancer (2015)

previous disabled Page of 2